Terzis Georgios 4

What Happened
Cosmos Health CFO Georgios Terzis was granted 850,000 restricted stock units (RSUs) on May 19, 2026 that vested immediately and converted into 850,000 shares of common stock. The filing values the shares at $0.28 each, for a total reported value of $240,550. The Form 4 shows an award/grant (code A) and a simultaneous conversion of a derivative security (code C) reflecting the RSUs converting to common shares.

Key Details

• Transaction date: May 19, 2026. Report filed June 11, 2026 (filed late relative to the usual 2-business-day Form 4 deadline).
• Price and value: 850,000 shares at $0.28 per share; total reported value $240,550.
• Transaction codes: A = award/grant; C = conversion of derivative security (RSUs → common stock).
• Shares owned after transaction: Not specified in the filing.
• Footnotes: Grants made under the Issuer’s 2024 & 2025 Omnibus Incentive Plan; RSUs vested on the grant date and transaction was reported as exempt under Rule 16b-3.

Context
This was an equity compensation grant (RSUs) rather than an open-market purchase or sale. Grants that vest immediately provide executive ownership but are typically part of compensation programs rather than a direct market signal. The late filing reduces timeliness of disclosure; late Form 4s can limit how quickly investors see insider activity.